lol. It was a study recommended by TGA and FDA. And is completely necessary to reduce the phase 3 trials from a cohort of 1000’s down to 300-350 over appx 7 centres i.e., about 60 patients per site.
Ann: NanaBis Observational Study - Impressive Start, page-3
Add to My Watchlist
What is My Watchlist?